ACTEMRA

Brand name authorized in: Australia Brazil Canada Hong Kong Singapore Tunisia United States

Active ingredients

The drug ACTEMRA contains one active pharmaceutical ingredient (API):

1 Tocilizumab
UNII I031V2H011 - TOCILIZUMAB

Tocilizumab binds specifically to both soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R). IL-6 is involved in diverse physiological processes such as T-cell activation, induction of immunoglobulin secretion, induction of hepatic acute phase protein synthesis and stimulation of haemopoiesis. IL-6 has been implicated in the pathogenesis of diseases including inflammatory diseases, osteoporosis and neoplasia.

Read about Tocilizumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Tocilizumab
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC07

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Structured product labeling (SPL/PLR)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 10056G, 10058J, 10060L, 10064Q, 10068X, 10071C, 10072D, 10073E, 10077J, 10078K, 10079L, 10081N, 10951J, 10954M, 11565Q, 11567T, 11720W, 11721X, 11722Y, 11725D, 11730J, 11734N, 11741Y, 11742B, 11743C, 11744D, 11748H, 11750K, 12083Y, 12084B, 12085C, 12086D, 12090H, 12094M, 12095N, 12099T, 12102Y, 12105D, 1419Q, 1423X, 1464C, 1476Q, 1481Y, 1482B, 9657G, 9658H, 9659J, 9671B, 9672C, 9673D
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 529208501150212, 529208502157210, 529215110026303, 529220090026707, 529220090026807
CA
Health Products and Food Branch
Identifier(s): 02350092, 02350106, 02350114, 02424770, 02483327
HK
Department of Health Drug Office
Identifier(s): 59200, 59201, 59202, 63771
SG
Health Sciences Authority
Identifier(s): 13723P, 14837P
US
FDA, National Drug Code
Identifier(s): 50242-135, 50242-136, 50242-137, 50242-138, 50242-143